Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value ($000): $450,693 (100.0% shares, 0.0% debt)

Holdings (9)

BVS BIOVENTUS 38.0%

Value ($000) $171,289 Shares 12,096,702 Est. Cost $14.24 Unrealized +8.0%

MDXG MIMEDX GROUP, INC. 31.4%

Value ($000) $141,662 Shares 23,376,623 Est. Cost $7.34 Unrealized +53.5%

EYPT EYEPOINT PHARMACEUTICALS INC 9.7%

Value ($000) $43,669 Shares 4,190,921 Est. Cost $4.68 Unrealized +103.8%

— VENUS CONCEPT, INC. 6.9%

Value ($000) $31,169 Shares 12,417,856 Est. Cost $4.17 Unrealized —

TELA TELA BIO, INC. 5.6%

Value ($000) $25,052 Shares 1,833,989 Est. Cost $13.08 Unrealized +6.6%

AXGN AXOGEN INC 4.5%

Value ($000) $20,171 Shares 1,276,645 Est. Cost $4.01 Unrealized +348.2%

— REVANCE THERAPEUTICS INC 2.9%

Value ($000) $13,166 Shares 472,590 Est. Cost $31.50 Unrealized —

MNOV MEDICINOVA INC 0.9%

Value ($000) $4,192 Shares 1,105,941 Est. Cost $2.95 Unrealized +28.8%

— CATALYST BIOSCIENCES INC 0.1%

Value ($000) $323 Shares 78,622 Est. Cost $7.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BVS	BIOVENTUS	12,096,702	$171,289	38.0%	$14.24	+8.0%	COM CL A	09075A108
MDXG	MIMEDX GROUP, INC.	23,376,623	$141,662	31.4%	$7.34	+53.5%	COM	602496101
EYPT	EYEPOINT PHARMACEUTICALS INC	4,190,921	$43,669	9.7%	$4.68	+103.8%	COM NEW	30233G209
—	VENUS CONCEPT, INC.	12,417,856	$31,169	6.9%	$4.17	—	COM	92332W105
TELA	TELA BIO, INC.	1,833,989	$25,052	5.6%	$13.08	+6.6%	COM	872381108
AXGN	AXOGEN INC	1,276,645	$20,171	4.5%	$4.01	+348.2%	COM	05463X106
—	REVANCE THERAPEUTICS INC	472,590	$13,166	2.9%	$31.50	—	COM	761330109
MNOV	MEDICINOVA INC	1,105,941	$4,192	0.9%	$2.95	+28.8%	COM NEW	58468P206
—	CATALYST BIOSCIENCES INC	78,622	$323	0.1%	$7.36	—	COM NEW	14888D208